News|Videos|January 22, 2025

Pharmapack Europe 2025: Packaging Trends

Author(s)Susan Haigney

Pharmaceutical Technology® sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the primary and secondary packaging solutions Gerresheimer and Bormioli Pharma will be showcasing at Pharmapack Europe 2025 in Paris, France from January 22–23.

As a preview of what’s to come at this year’s Pharmapack Europe event, being held on January 22–23 in Paris, France, Pharmaceutical Technology® sat down with Stefan Verheyden, Global Vice President Sales Pharma & Biopharma Solutions Injectables at Gerresheimer, to talk about the different packaging solutions the company has to offer. The company will be jointly exhibiting with the newly acquired Bormioli Pharma.

At the event, Gerresheimer will be featuring its primary packaging solutions and delivery systems for sensitive biologics, such as its EZ-fill Smart packaging platform for ready-to-fill (RTF) vials and cartridges. Gerresheimer’s Gx Elite syringes, cartridges, and vials offer protection for injectable drugs, especially novel biologics, says the company (1).

Verheyden sees a trend toward at-home therapy and personalized medicine, and Gerresheimer offers autoinjectors and other drug delivery devices to accommodate this trend.

“[Our] devices actually enable a very simple, patient-friendly application with high precision dosing of the respective medication, which I think is very important. And then on top of that, [our] on-body drug delivery device can actually be digitally monitored, which I think for healthcare professionals is also very interesting, because they can pretty easily monitor the patient and how he's actually been fulfilling his treatment,” says Verheyden.

“[Gerresheimer is] becoming an organization that focuses on solutions in specific domains. Yeah, what we want to make sure … we understand what the market needs, and that we anticipate those needs. And therefore, we think it is very important that we understand very well what happens in specific … disease areas, [for example], chronic disease, … repetitive treatments, oncology, all the diseases where we think a more customized product offering could be of an added value,” Verheyden says.

Gerresheimer and Bormioli Pharma can be found at booth F55 at Pharmapack in Paris Expo, Porte de Versailles from Jan. 22–23, 2025.

Click the above video to watch the full interview.

For more Pharmapack news, visit our conference page.

Reference

1. Gerresheimer. Two Stories–One Future. Gerresheimer and Bormioli Pharma at Pharmapack 2025. Press Release. Jan. 20, 2025.


Related to this article

TILE-X with NEBULA. Image courtesy of IMA Group.
The IMA Pharmaceutical and MedTech divisions will be highlighting the TILE-X fill-finish line, a new VPHP BioIndicator, X-PEN autoinjector platform, and a range of machines from its IMA Active, IMA Life, IMA Safe, and IMA BFB divisions at the CPHI Milan event.
Putting Sustainability to Work in Pharma
Silvia Forroova, director of Partnerships & Sustainability at CPHI, and founder of the CPHI Sustainability Collective, provides a preview of the new Sustainability Summit at CPHI Milan 2026.
AAPS PharmSci 360: CMC Strategies, Part 2
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss navigating CMC requirements for new modalities and AI’s involvement in CMC.
AAPS PharmSci 360: CMC Strategies, Part 1
In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discussed how CMC review practices are evolving and what that means for manufacturing strategy.
Medical award concept, winner cup on the desk | Image Credit: ©BillionPhotos.com -stock.adobe.com
The finalists for the 2026 CPHI Pharma Awards span 15 categories including API development, digital transformation, manufacturing, supply chain, sustainability, and leadership, with winners revealed October 6 at CPHI Milan.